HemaSphere
(Jun 2022)
PB2179: RETROSPECTIVE ANALYSIS OF THE EFFICACY AND SAFETY OF RUXOLITINIB IN CHRONIC GRAFT VERSUS HOST DISEASE (CGVHD). A SINGLE-INSTITUTION EXPERIENCE.
Ó. Muñiz,
T. Torrado Chedas,
A. Nieto Vazquez,
A. Santamaria Lopez,
E. Winsnes,
L. González Rodríguez,
C. Albo Lopez
Affiliations
Ó. Muñiz
1 Hospital Álvaro Cunqueiro, Vigo, Spain
T. Torrado Chedas
1 Hospital Álvaro Cunqueiro, Vigo, Spain
A. Nieto Vazquez
1 Hospital Álvaro Cunqueiro, Vigo, Spain
A. Santamaria Lopez
1 Hospital Álvaro Cunqueiro, Vigo, Spain
E. Winsnes
1 Hospital Álvaro Cunqueiro, Vigo, Spain
L. González Rodríguez
1 Hospital Álvaro Cunqueiro, Vigo, Spain
C. Albo Lopez
1 Hospital Álvaro Cunqueiro, Vigo, Spain
DOI
https://doi.org/10.1097/01.HS9.0000851544.57756.33
Journal volume & issue
Vol. 6
pp.
2049
– 2050
WeChat QR code
Close